Studies investigating the role of NKG2C deletion in the defence against virus infections focused so far on HCMV, especially in solid organ and haematopoietic stem cell transplant patients and COVID-19 patients [15, 22, 23]. The gene discussed is KLRC2; the disease is viral infectious disease.